A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer
Status:
Recruiting
Trial end date:
2020-12-12
Target enrollment:
Participant gender:
Summary
This is a single-center phase II study designed to evaluated the efficacy and safety of
fulvestrant in combination with oral vinorelbine in hormone receptor-positive advanced breast
cancer